Podocyte Biology in Kidney Disease

Podocytes are highly specialised epithelial cells that line the outer aspect of glomerular capillaries and form an essential component of the filtration barrier. Each podocyte extends interdigitating foot processes that are connected by a specialised slit diaphragm, a dynamic structure that restricts the passage of plasma proteins into the urinary space. Integrity of the actin‐rich cytoskeleton and its focal adhesion contacts with the glomerular basement membrane is critical for maintaining filtration selectivity and structural resilience. Injury to podocytes in conditions such as diabetic nephropathy, focal segmental glomerulosclerosis and drug‐induced nephrotoxicity leads to effacement of foot processes, detachment from the basement membrane and eventual podocyte loss. This loss precipitates proteinuria and progressive glomerulosclerosis. Advances in understanding signalling pathways—such as Hippo–YAP, Notch and integrin‐mediated mechanotransduction—have highlighted how alterations in mechanical forces, transcriptional coactivators and cell‐cycle regulators drive podocyte dysfunction. Improved in vitro models and in vivo studies have elucidated mechanisms of podocyte injury and repair, informing novel therapeutic strategies aimed at preserving podocyte number and function to retard progression to end‐stage renal disease.

Research from Nature Portfolio

Recent studies have demonstrated that exposure to certain kinase inhibitors disrupts podocyte biomechanics by altering actin cytoskeletal architecture and focal adhesion dynamics, leading to foot process effacement and reversible glomerular dysfunction in animal models. Phosphoproteomic and kinome profiling have pinpointed molecular mediators of cytoskeletal injury, offering avenues for safer therapeutic design. In parallel, a tunable gelatin‐based platform that mimics the mechanical stiffness of healthy glomeruli has been shown to support podocyte differentiation and maturation in vitro. This biomimetic system has revealed key mechanotransduction pathways linking substrate stiffness to the expression of filtration‐related markers, providing a powerful tool for disease modelling and drug screening.

Podocyte Biology in Kidney Disease publication trend

The graph below shows the total number of articles in podocyte biology in kidney disease across all publications each year (not limited to Nature Index journals).

Technical terms

Podocyte: A specialised glomerular epithelial cell with interdigitating foot processes critical to the filtration barrier.

Glomerular filtration barrier: The three‐layered structure comprising fenestrated endothelium, basement membrane and podocytes that retains proteins in the circulation.

Slit diaphragm: A multi-protein junction between podocyte foot processes that regulates permeability to plasma proteins.

Cytoskeleton: A network of actin filaments and associated proteins that maintains cell shape, adhesion and mechanical resilience.

Mitotic catastrophe: A form of cell death caused by aberrant mitosis and failed cytokinesis, often leading to multinucleation.

YAP (Yes-associated protein): A transcriptional coactivator in the Hippo pathway that regulates cell survival and differentiation.

WT1 (Wilms tumour protein): A zinc-finger transcription factor essential for podocyte gene expression and phenotypic maintenance.

References

1. Profilin1 is required to prevent mitotic catastrophe in murine and human glomerular diseases. Journal of Clinical Investigation (2023).
2. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury. Kidney International (2024).
3. Disruption of podocyte cytoskeletal biomechanics by dasatinib leads to nephrotoxicity. Nature Communications (2019).
4. A biomimetic gelatin-based platform elicits a pro-differentiation effect on podocytes through mechanotransduction. Scientific Reports (2017).